Harvard Bioscience Inc
NASDAQ:HBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
US |
|
E
|
Eni SpA
XHAM:ENI
|
IT |
|
P
|
Persol Holdings Co Ltd
TSE:2181
|
JP |
|
H
|
Hecla Mining Co
F:HCL
|
US |
|
Harmony Gold Mining Company Ltd
F:HAM1
|
ZA |
|
N
|
NetApp Inc
DUS:NTA
|
US |
|
L
|
LPL Financial Holdings Inc
F:7LI
|
US |
|
Open House Group Co Ltd
OTC:OPPPF
|
JP |
|
DSV A/S
F:DS81
|
DK |
|
J
|
Jabil Inc
DUS:JBL
|
US |
|
M
|
Mfe-Mediaforeurope NV
MIL:MFEB
|
IT |
|
C
|
CBRE Group Inc
F:RF6
|
US |
|
D'Ieteren Group SA
XBRU:DIE
|
BE |
|
SM Energy Co
NYSE:SM
|
US |
|
Unico Silver Ltd
ASX:USL
|
AU |
|
Washington H. Soul Pattinson and Company Ltd
OTC:WSOUF
|
AU |
|
Tharisa PLC
OTC:TIHRF
|
CY |
|
H
|
H & R Block Inc
XMUN:HRB
|
US |
|
M
|
Microsoft Corp
DUS:MSF
|
US |
Wall St Price Targets
HBIO Price Targets Summary
Harvard Bioscience Inc
According to Wall Street analysts, the average 1-year price target for
HBIO is 7.65 USD with a low forecast of 7.58 USD and a high forecast of 7.88 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HBIO's stock price target?
Price Target
7.65
USD
According to Wall Street analysts, the average 1-year price target for
HBIO is 7.65 USD with a low forecast of 7.58 USD and a high forecast of 7.88 USD.
What is the Revenue forecast for Harvard Bioscience Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 2 years is 6%.
What is the Gross Profit forecast for Harvard Bioscience Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 2 years is 8%.